ici 215001 has been researched along with cyclic gmp in 1 studies
Studies (ici 215001) | Trials (ici 215001) | Recent Studies (post-2010) (ici 215001) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
---|---|---|---|---|---|
8 | 0 | 2 | 22,346 | 333 | 4,062 |
Protein | Taxonomy | ici 215001 (IC50) | cyclic gmp (IC50) |
---|---|---|---|
Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bernabeo, G; Borda, E; Ganzinelli, S; Joensen, L; Sterin-Borda, L | 1 |
1 other study(ies) available for ici 215001 and cyclic gmp
Article | Year |
---|---|
Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.
Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Heart Rate; Male; Mice; Mice, Knockout; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phenoxyacetates; Phenoxypropanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Signal Transduction | 2006 |